BLM, GST-Tag Recombinant

Only %1 left
Catalog #
102130
As low as $450 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human BLM (Bloom syndrome protein, also known as BLM RecQ like helicase), encompassing amino acids 630-1300. This construct contains a N-terminal GST-tag followed by a thrombin cleavage site. This protein was affinity purified.

Synonyms
RecQ-like DNA helicase BLM, Bloom syndrome protein, DNA 3'-5' helicase BLM, DNA helicase, RecQ-like type 2 (RecQ2), RecQ protein-like 3, RECQ2, RECQL3
Product Info
Storage and Usage
Citations
Species
Human
Construct
BLM (GST-Th-630-1300)
Host Species/Expression System
Sf9
Purity

≥90%

Format

Aqueous buffer solution.

Formulation

40 mM Tris-HCl, pH 8.0, 200 mM NaCl, 2.2 mM KCl, 0.04% Tween-20, 20% glycerol, and 1 mM TCEP

MW
102 kDa
Amino Acids
630-1300
Genbank #
NM_000057.4
UniProt #
P54132
Tag(s)
N-Terminal GST Tag
Background

The BLM helicase, also known as Bloom syndrome protein, is a key enzyme involved in DNA replication and repair (DDR). The BLM helicase is a member of the RecQ family of helicases, which are evolutionarily conserved and found in many organisms, including bacteria, yeast, and humans. It catalyzes the unwinding of duplex DNA with 3’ to 5’ directionality, driven by the energy generated from ATP hydrolysis. BLM plays a crucial role in maintaining genomic stability by unwinding DNA structures during processes such as DNA replication, recombination, and repair. Mutations in the BLM gene can lead to Bloom syndrome, a rare genetic disorder characterized by growth deficiency, sun-sensitive skin lesions, and an increased risk of cancer. High expression of BLM is found in glioblastoma, and it was found that inhibition of its activity leads to increased susceptibility to treatment with drugs targeting other proteins involved in DDR, such as PARP1 (poly-ADP ribosylation protein 1). The use of BLM inhibitors as part of a combinatory therapeutic approach may open new avenues of treatment in cancer therapy.